The study enrolled 25 patients with high-grade bladder cancer that had come back after earlier BCG treatment. Their median age was 68. About two-thirds (17 patients) had carcinoma in situ, a flat, ...

A new urine test could make bladder cancer easier to detect — and help doctors figure out which treatments are most likely to ...

Patients with muscle-invasive bladder cancer can now receive NHS treatment with a regimen of MSD's Keytruda and Astellas' ...

Andrea Necchi, MD, discusses response-adapted treatment, higher complete response rates, and the potential to reduce the need ...

Treatments for bladder cancer include surgery, chemotherapy, and radiation therapy. Newer treatment options include immunotherapy and targeted therapy. Doctors may administer medications directly into ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

On October 14, the U.S. Food and Drug Administration announced that Anktiva (nogapendekin alfa inbakicept-pmln), used together with Bacillus Calmette-Guérin, is now approved for adults with ...

Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...

Advanced bladder cancer is particularly difficult to treat, with few options available to doctors. Often, the first line of treatment is chemotherapy with or without radiation. Treatments for advanced ...

"There was blood in my urine, but it didn't hurt at all.""It went back to a normal color the next time I went to the bathroom ...

MRK] outside of Canada) and USA, today welcomes news that the National Institute for Health and Care Excellence (NICE) has recommended the use of MSD’s Keytruda (pembrolizumab) with Astellas’ (TYO: ...